Solasia Pharma KK (TSE:4597) Total Receivables: 円22.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4597 Solasia Pharma KK TSE:4597
65 GF Score
Price 円30.00
GF Value 円30.91
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Solasia Pharma KK Total Receivables?

Solasia Pharma KK TSE:4597 +3.45% 65 Total Receivables is 円22.0 Mil as of Jun. 2026. GuruFocus rates TSE:4597 with a GF Score™ of 65/100 and a GF Value™ of 円30.91 (Fairly Valued). The stock has 5 warning signs investors should review.

Solasia Pharma KK's Total Receivables for the quarter that ended in Jun. 2026 was 円22.0 Mil.

Solasia Pharma KK Total Receivables Related Terms

Solasia Pharma KK Total Receivables Historical Data

* Premium members only.

The historical data trend for Solasia Pharma KK's Total Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Solasia Pharma KK Total Receivables Chart

Solasia Pharma KK Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Total Receivables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 126.00 572.00 67.00 203.00 341.00

Solasia Pharma KK Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Total Receivables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26.00 75.00 341.00 19.00 22.00
TSE:4597
65GF Score
Solasia Pharma KK TSE:4597
Total Receivables is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Solasia Pharma KK Total Receivables Calculation

Total Receivables is the sum of all receivables owed by customers and affiliates within one year, including:
Accounts Receivable
Notes Receivable
Loans Receivable
Other Current Receivables

Frequently Asked Questions Learn more about Total Receivables →
What does a Total Receivables of 円22.0 Mil mean?
Solasia Pharma KK (TSE:4597) has a Total Receivables of 円22.0 Mil as of Jun. 2026. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Solasia Pharma KK and its competitors.
Is Solasia Pharma KK's Total Receivables too high?
Solasia Pharma KK's current Total Receivables is 円22.0 Mil. Overall, Solasia Pharma KK has a GF Score™ of 65/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Solasia Pharma KK's Total Receivables compare to ZTS?
Solasia Pharma KK's Total Receivables of 円22.0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Receivables for a Drug Manufacturers company?
A good Total Receivables depends on the Drug Manufacturers industry context. However, Total Receivables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Receivables mean?
A high Total Receivables can signal that a stock is expensive relative to its fundamentals. Total Receivables is the sum of all receivables owed by customers and affiliates within one year. View historical data on Solasia Pharma KK and its competitors. Solasia Pharma KK's current Total Receivables is 円22.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Solasia Pharma KK stock overvalued right now?
Based on GuruFocus' analysis, Solasia Pharma KK (TSE:4597) is currently considered Fairly Valued. The stock's GF Value™ is 円30.91, compared to a current price of 円30.00 — trading 2.9% below its estimated fair value. The current Total Receivables is 円22.0 Mil. Solasia Pharma KK's overall GF Score™ is 65/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Receivables calculated?
Total Receivables is calculated from a company's financial statements. For Solasia Pharma KK (TSE:4597), the current Total Receivables is 円22.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Solasia Pharma KK (TSE:4597) Overvalued in 2026?

Based on GuruFocus' analysis, Solasia Pharma KK stock appears to be undervalued. The current stock price of 円30.00 is trading 2.9% below its estimated GF Value™ of 円30.91. GuruFocus considers Solasia Pharma KK to be Fairly Valued.

Key valuation signals for TSE:4597:

  • Total Receivables: 円22.0 Mil
  • GF Value™: 円30.91 vs. price of 円30.00 (2.9% below fair value)
  • GF Score™: 65/100 with 5 warning signs

No single metric tells the full story. See the TSE:4597 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Solasia Pharma KK Business Description

Other Exchanges 9SO:Germany
Address 2-1-1 Shiba Park, 4th Floor, Sumitomo Real Estate Shiba Park Tower, Minato-ku, Tokyo, JPN, 105-0011
Solasia Pharma KK develops and distributes pharmaceuticals and medical devices relating to malignant tumors.
65GF Score

Get the complete analysis for TSE:4597

Total Receivables is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円30.00
Price
円30.91
GF Value